🔎 Trials Near Me

Home › Seizures › Washington

Seizures clinical trials in Washington, DC

13 studies for Seizures are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Investigating Epilepsy: Screening and Evaluation

RecruitingObservational study
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 8 to 110 · All sexes · Updated Oct 2, 2026 · NCT03478852

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

RecruitingObservational studyHealthy volunteers welcome
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 3 to 99 · All sexes · Updated Oct 2, 2026 · NCT00001205

Tumor Related Epilepsy

RecruitingObservational study
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 8 to 99 · All sexes · Updated Oct 2, 2026 · NCT02639325

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

RecruitingPhase 1
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi away
Ages 12 to 75 · All sexes · Updated Oct 2, 2026 · NCT07233239

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

RecruitingPhase 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi away
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07563881

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

RecruitingPhase 2
  • Mid Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi away
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT06798896

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

RecruitingPhase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 60 · All sexes · Updated Sep 28, 2026 · NCT02531880

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

RecruitingPhase 3
  • George Washington University, Washington D.C.
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

RecruitingPhase 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100

Pediatric Dose Optimization for Seizures in Emergency Medical Services

RecruitingPhase 3
  • Children's National Hospital, Washington D.C.
6 Months – 13 Years · All sexes · Updated Sep 30, 2025 · NCT05121324

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

RecruitingPhase 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi away
Ages 4 to 55 · All sexes · Updated Jul 24, 2025 · NCT05219617

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

RecruitingPhase 2
  • Praxis Research Site, Bethesda · 7 mi away
Ages 18 to 75 · All sexes · Updated Apr 3, 2025 · NCT06908356

Epilepsy Learning Healthcare System (ELHS)

RecruitingObservational study
  • Epilepsy Foundation, Bowie · 17 mi away
All ages · All sexes · Updated Aug 30, 2024 · NCT06265103

About Seizures

Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.

More about Seizures on MedlinePlus

Seizures trials in other cities

Other studies in Washington

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.